30th April 2020
National Hellenic Research Foundation offers end-to-end support for COVID-19 drug discovery and development
The Biomarkers Discovery & Translational Research laboratory at National Hellenic Research Foundation performs Absorption, Distribution, Metabolism, Elimination and Toxicology studies and multi-omics approaches for end-to-end drug discovery and development.
They are able to support industry and academia with COVID-19 drug discovery and development from fit for purpose to full compliance. The team advises on study design, analytical methodology and pull through from nonclinical to clinical use, plus companion diagnostics regulatory submissions.
ASK: Research contributors needed for CON-VICE study
University of Luxembourg needs European researchers to get in touch
OFFER: Funding available for COVID-19 research
Fondation Air Liquide are looking to fund European projects
ASK: Supporting the immunocompromised
Partners sought to advance neutralising antibody